◆ 会议时间：2025年8月21-23日
◆ 会议地点：澳大利亚 悉尼
◆ 会议简介：
2025年25届亚太地区前列腺癌大会(APCC2025)将于2025年8月21-23日在澳大利亚悉尼举行，会议由澳大利亚前列腺中心主办。届时，前列腺癌临床管理和研究领域宣的世界级领导者将齐聚一堂，分享他们丰富的知识和经验，讨论前列腺癌管理的各个方面，包括治疗和科学进展。本次会议将再次拥有一批优秀的国际师资队伍，为代表们提供一个有关前列腺癌研究和治疗的全球视角。本次会议预计将吸引来自国内外的800余名代表参会。未经许可禁止复制转载摘录镜像本站任何内容-国际医学会议网(lingyuint.com)。
第25届亚太前列腺癌大会
25th Asia-Pacific Prostate Cancer Conference (APCC 2025)
Date:
21-23 August, 2025
Venue:
Hilton Sydney, Australia
Organized by:
Australian Prostate Centre (APC)
摘要征文投稿：
| Abstract submissions open |
Tuesday 11 February |
| Abstract submissions close |
Friday 11 April |
| Notifications sent to authors |
Wednesday 14 May |
| Author acceptances and registrations due |
Wednesday 21 May |
点此提交摘要>>>Submit Abstract>>>
PRESENTATION TYPES
APCC is accepting abstracts for the following streams:
- Clinical Urology
- Radiation Oncology
- Nuclear Medicine
- Nursing & Allied Health
The program committee is particularly interested in submissions with a focus on integrating artificial intelligence into prostate cancer diagnostic and treatment algorithms, next generation targeted therapies and the increasing role of metastasis directed therapies.
You must indicate the type of presentation when submitting online. The final decision on acceptances and on publication and presentation formats are at the discretion of the Convening Committee.
Oral Presentation (15 minutes) - NEW FOR 2025!
A 15 minute oral presentation to be included in one of the Conference concurrent sessions. Scheduled presentation time will be provided upon acceptance to the program. Please note a limited number of oral presentations will be accepted. In the event that we are unable to offer you a speaking slot you may be offered a rapid fire or poster presentation.
For those submitting under the Nursing & Allied Health theme, we will also ask you to provide a digital poster to support your presentation and this will be eligible for consideration for the Helen Crowe Poster Award.
Rapid Fire Presentation (5 minutes)
An electronic or printed poster will be displayed at the venue for the duration of the Conference. The format of the poster (electronic or printed) will be confirmed to presenters upon their acceptance into the program.
A digital version of your poster (1 x 16:9 PowerPoint Slide) will be required to be submitted via the Conference platform which will then be available on the Conference app for delegates to view.
A short 5 minute PowerPoint Presentation with a maximum of 3–4 slides will be required to present your Rapid Fire Presentation at the Conference. Further information will be provided upon acceptance to the program.
Poster Only
An electronic or printed poster will be displayed at the venue for the duration of the Conference. The format of the poster (electronic or printed) will be confirmed to presenters upon their acceptance into the program.
A digital version of your poster (1 x 16:9 PowerPoint Slide) will be required to be submitted via the Conference platform which will then be available on the Conference app for delegates to view.
ABSTRACT GUIDELINES
- Abstracts must be presented in English and be a piece of original work. Encore or previously presented abstracts will not be accepted.
- Abstracts are limited to 300 words, excluding author(s) names, affiliations, organisations and references.
- Results must be included. Abstracts with "results will be presented" statement will not be considered.
- If the abstract is submitted by someone other than the presenter, the author(s) and presenter must be clearly identified.
Please submit your abstract in the following format:
- Abstract title and text should be entered in upper and lower case. Please do not use all capital letters in your abstract title.
- There is a maximum of 300 words for the abstract.
- The abstract should include objectives, methods, results and conclusions.
- Conclusions of the form - “Results will be discussed” - are not acceptable.
- Only standard abbreviations may be used.
ABSTRACT TEMPLATE
Please click on the button below to download and save the abstract submission template.
Abstract submission template
ABSTRACT SUBMISSIONS
Once submitted, abstracts can be amended via the portal up until the submission due date of Friday 11 April.
Abstract review results will be communicated to the corresponding authors via email on Wednesday 14 May.
The details provided as the author contact should be for the nominated main contact for your abstract. All correspondence relating to the submission will be directed to this person and they should in turn distribute to all co-presenters.
Acceptance of this offer must be notified to the Conference Office by no later than Wednesday 21 May.
ABSTRACT PRESENTER REGISTRATION
The invitation to submit an abstract does not constitute an offer to pay travel, accommodation or registration costs associated with the Conference. Similarly, no presenter fee is paid to successful participants.
Presentations must be delivered in person and the ability and willingness to present in Sydney will be a condition of acceptance into the program.
It is a requirement that the nominated presenter of all successful abstract submissions is registered to attend the Conference.
All presenters must register for the Conference before 5pm AEST on Wednesday 21 May in order for their presentation to be included in the Conference program.
We are proud to present the 25th Asia-Pacific Prostate Cancer Conference. It’s remarkable to reflect on a quarter of a century of advances in prostate cancer care since the conference first began.
Prostate cancer remains a significant health concern as we enter 2025, profoundly impacting the lives of countless men diagnosed daily in Australia and worldwide. Thanks to the many innovations over the past decade, men are living longer and with improved quality of life, even when diagnosed with advanced disease. But still more needs to be done.
The conference will continue to expand on the themes of 2024, with a focus on integrating artificial intelligence into prostate cancer diagnostic and treatment algorithms, next generation targeted therapies and the increasing role of metastasis directed therapies. We will explore treatment intensification and sequencing, the role of immunotherapy in prostate cancer and 2025 will see a return of the robotic surgery masterclass. For our nursing and allied health attendees we will be highlighting innovative advancements in survivorship whilst covering critical topics including genomics, sexual rehabilitation, health equity, and the management of patients undergoing doublet and triplet therapies.
For the first time, the meeting will be held in Sydney, where we will engage with a wider clinical urology and nursing and allied health audience.
We look forward to seeing and engaging with you there!
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
